Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander J Thompson
Matthew Sutton
Katherine Payne

Showing results (1-10 of 390) with videos related to

Pageof 39
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Estimating Joint Health Condition Utility ValuesAlexander J Thompson, Matthew Sutton, Katherine Payne
Expert Review of Precision Medicine and Drug Development|April 24, 2018
The economic case for precision medicineSean P Gavan, Alexander J Thompson, Katherine Payne
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 4, 2024
International Systematic Review of Utility Values Associated with Cardiovascular Disease and Reflections on Selecting Evidence for a UK Decision-Analytic ModelRob Hainsworth, Alexander J Thompson, Bruce Guthrie, et al.
Nature Reviews. Genetics|January 23, 2018
Cost-effectiveness analyses of genetic and genomic diagnostic testsKatherine Payne, Sean P Gavan, Stuart J Wright, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 21, 2014
The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprineAlexander J Thompson, William G Newman, Rachel A Elliott, et al.
The Lancet. Healthy Longevity|June 8, 2021
Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort studyShona Livingstone, Daniel R Morales, Peter T Donnan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with PsoriasisNiall J Davison, Alexander J Thompson, Alexander J Turner, et al.
Health Economics|October 13, 2009
Fish and chips all round? Regulation of DNA-based genetic diagnosticsKatherine Payne
Pharmacogenomics|December 25, 2007
Towards an economic evidence base for pharmacogenetics: consideration of outcomes is keyKatherine Payne
Archives of Internal Medicine|September 28, 2011
Ignorance is bliss?Matthew Sutton
Pageof 39

Showing results (1-10 of 390) with videos related to

Sort By:
Pageof 39
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Estimating Joint Health Condition Utility ValuesAlexander J Thompson, Matthew Sutton, Katherine Payne
Expert Review of Precision Medicine and Drug Development|April 24, 2018
The economic case for precision medicineSean P Gavan, Alexander J Thompson, Katherine Payne
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 4, 2024
International Systematic Review of Utility Values Associated with Cardiovascular Disease and Reflections on Selecting Evidence for a UK Decision-Analytic ModelRob Hainsworth, Alexander J Thompson, Bruce Guthrie, et al.
Nature Reviews. Genetics|January 23, 2018
Cost-effectiveness analyses of genetic and genomic diagnostic testsKatherine Payne, Sean P Gavan, Stuart J Wright, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 21, 2014
The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprineAlexander J Thompson, William G Newman, Rachel A Elliott, et al.
The Lancet. Healthy Longevity|June 8, 2021
Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort studyShona Livingstone, Daniel R Morales, Peter T Donnan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with PsoriasisNiall J Davison, Alexander J Thompson, Alexander J Turner, et al.
Health Economics|October 13, 2009
Fish and chips all round? Regulation of DNA-based genetic diagnosticsKatherine Payne
Pharmacogenomics|December 25, 2007
Towards an economic evidence base for pharmacogenetics: consideration of outcomes is keyKatherine Payne
Archives of Internal Medicine|September 28, 2011
Ignorance is bliss?Matthew Sutton
Pageof 39